Effects of Phosphate Binders in Moderate CKD - Block, Geoffrey A.; Wheeler, David C.; Persky, Martha S.; Kestenbaum, Bryan; Ketteler, Markus; Spiegel, David M.; Allison, Matthew A.; Asplin, John; Smits, Gerard; Hoofnagle, Andrew N.; Kooienga, Laura; Thadhani, Ravi; et al. (Journal of the American Society of Nephrology, 2012)
Keywords: Acetates - therapeutic use; Aged; Aged, 80 and over; Biological and medical sciences; Bone Density - drug effects; Calcium Compounds - therapeutic use; Chelating Agents - therapeutic use; Clinical Research; Drug toxicity and drugs side effects treatment; Female; Fibroblast Growth Factors - blood; Humans; Hyperphosphatemia - etiology; Hyperphosphatemia - prevention & control; Kidneys; Lanthanum - therapeutic use; Male; Medical sciences; Middle Aged; Nephrology. Urinary tract diseases; Parathyroid Hormone - blood; Pharmacology. Drug treatments; Phosphates - blood; Phosphates - urine; Pilot Projects; Polyamines - therapeutic use; Renal Insufficiency, Chronic - complications; Sevelamer; Toxicity: cardiovascular system; Urinary system involvement in other diseases. Miscellaneous; Vascular Calcification - chemically induced; Endocrinopathy; Kidney disease; Human; Phosphates; Nephrology; Urinary system disease; Toxicity; Cardiovascular disease; Chronic kidney disease; Urology; Vascular disease; Treatment; Parathyroid diseases; Renal failure; Calcification; Chelating agent; Complication; Hyperparathyroidism